Integrated Marketing Solutions.
DevicePharm provides marketing strategy and integrated marketing solutions for organizations serving medical professionals and healthcare consumers. Our commitment is to help our clients – medical device, biotech, and life science companies – navigate From Opportunity To Success™.Get Started Today Request a Portfolio
Recent Posts / View All Posts
Every medical marketer wants to know one thing, “What are my customers thinking?”. On November 10, 2016, DevicePharm and Medical Alley will co-host an event designed to answer that very question. Titled ‘Medical Device Marketing Through the Eyes of Your Customers’, this event will feature a panel that includes surgeons, interventionalists, and hospital and practice executives from the Twin Cities area.
Much-anticipated breast cancer results from the prospective, randomized clinical study known as MINDACT were published in the August 24, 2016 edition of the New England Journal of Medicine. The MINDACT study evaluated the MammaPrint® 70-Gene Breast Cancer Recurrence Assay in 6,693 patients to determine its ability to help physicians identify which early-stage breast cancer patients would, and would not, likely benefit from chemotherapy.
SkylineDx debuted its new MMprofiler™ with SKY92 campaign this year during the European Hematology Association conference in Denmark. MMprofiler with SKY92 enables physicians to quickly and confidently identify high-risk multiple myeloma patients.
DevicePharm, a marketing strategy and integrated marketing solutions firm, is pleased to announce the promotion of Joseph Bañuelos to Vice President, Creative Director. Joseph is a proven leader in brand development and campaign creation for healthcare marketing.
We have helped our clients successfully define and launch over 500 medical brands.
We are bold in the expanse of our ideas and the action of our execution.
We employ sophisticated approaches and processes to deliver executable solutions.
We support each client with an integrated team of seasoned experts.